PORSAV scientific leaders Palliare Limited, an emerging company with the vision to create a safer operating room, announced the closing of an oversubscribed $8 million Series A funding round. The funds will be used to support US commercial launch activities related to Palliare’s EVA15 insufflator and smoke evacuation system, as well as new Research & Development activities, including PORSAV outputs.
There has been growing awareness of the hazardous nature of surgical smoke to the operating room staff, and various medical organizations in the USA have been lobbying for the safe evacuation of all surgical smoke. The COVID-19 pandemic further heightened awareness across the clinical community of the exposure of medical staff to aerosolized viruses in the operating room. In 2021 alone, nine (9) US states have introduced smoke evacuation bills, and more are anticipated in the coming months.
Read the full announcement in the press release here.